Literature DB >> 2061716

The Purkinje cell and its afferents in human hereditary ataxia.

A H Koeppen1.   

Abstract

The cerebellar cortex in patients with autosomal dominant and recessive ataxia was studied by Golgi impregnation and immunocytochemistry in order to gain further insight into the pathogenesis of neuronal atrophy which accompanies these disorders. Monoclonal antisera were used to visualize phosphorylated and non-phosphorylated neurofilament proteins, and a synapse-specific protein (P38; synaptophysin). Golgi stain and immunocytochemistry for non-phosphorylated neurofilament protein revealed partial or complete loss of distal Purkinje cell dendrities in the dominant cases and in one recessive case. Many preserved parallel fibres were shown by the monoclonal antibody to phosphorylated neurofilament protein. This antibody also gave strong reaction product in torpedoes. Axosomatic and axodendritic terminals on Purkinje cells were reduced in number, and loss of mossy fiber terminals was revealed by monoclonal anti-P38. The described methods provided additional morphological evidence of the heterogeneity of the hereditary ataxias. Purkinje cell atrophy progressed from loss and simplification of the dendritic tree to disappearance of the cell body. While these cells appeared to be especially vulnerable, other neurons of the molecular and granular layers were not exempt. There was evidence that at least some extracerebellar afferents, such as mossy fibers, were also affected by the disease process.

Entities:  

Mesh:

Year:  1991        PMID: 2061716     DOI: 10.1097/00005072-199107000-00010

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Pathogenic polyglutamine proteins cause dendrite defects associated with specific actin cytoskeletal alterations in Drosophila.

Authors:  Sung Bae Lee; Joshua A Bagley; Hye Young Lee; Lily Yeh Jan; Yuh-Nung Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations.

Authors:  H B Clark; E N Burright; W S Yunis; S Larson; C Wilcox; B Hartman; A Matilla; H Y Zoghbi; H T Orr
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

3.  Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis.

Authors:  Tslil Ast; Joshua D Meisel; Shachin Patra; Hong Wang; Robert M H Grange; Sharon H Kim; Sarah E Calvo; Lauren L Orefice; Fumiaki Nagashima; Fumito Ichinose; Warren M Zapol; Gary Ruvkun; David P Barondeau; Vamsi K Mootha
Journal:  Cell       Date:  2019-04-25       Impact factor: 41.582

Review 4.  The pathogenesis of spinocerebellar ataxia.

Authors:  Arnulf H Koeppen
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

5.  Deep Brain Stimulation of the Interposed Nucleus Reverses Motor Deficits and Stimulates Production of Anti-inflammatory Cytokines in Ataxia Mice.

Authors:  Gajendra Kumar; Pallavi Asthana; Wing Ho Yung; Kin Ming Kwan; Chung Tin; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2022-05-17       Impact factor: 5.590

6.  Structural study of Purkinje cell axonal torpedoes in essential tremor.

Authors:  Elan D Louis; Hong Yi; Cordelia Erickson-Davis; Jean-Paul G Vonsattel; Phyllis L Faust
Journal:  Neurosci Lett       Date:  2008-11-24       Impact factor: 3.046

7.  Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.

Authors:  S E Dougherty; J L Reeves; E K Lucas; K L Gamble; M Lesort; R M Cowell
Journal:  Exp Neurol       Date:  2012-05-02       Impact factor: 5.330

8.  Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia.

Authors:  Kevin C Kemp; Amelia J Cook; Juliana Redondo; Kathreena M Kurian; Neil J Scolding; Alastair Wilkins
Journal:  Acta Neuropathol Commun       Date:  2016-05-23       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.